<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39100135</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7090</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Journal of pain research</Title><ISOAbbreviation>J Pain Res</ISOAbbreviation></Journal><ArticleTitle>Clinical Characterization of New-Onset Chronic Musculoskeletal Pain in Long COVID: A Cross-Sectional Study.</ArticleTitle><Pagination><StartPage>2531</StartPage><EndPage>2550</EndPage><MedlinePgn>2531-2550</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/JPR.S466294</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">New-onset chronic musculoskeletal (MSK) pain is one of the common persistent symptoms in Long COVID (LC). This study investigated its clinical characteristics, underlying mechanisms, and impact on function, psychological health, and quality of life.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">Thirty adults (19 female, 11 male) with LC and new-onset chronic MSK pain underwent clinical examination, Quantitative Sensory Testing (QST), and blood tests for inflammatory markers and completed the following outcome measures: Timed Up and Go test (TUG), handgrip strength test, COVID-19 Yorkshire Rehabilitation Scale (C19-YRS), Brief Pain Inventory (BPI), Pain Self-Efficacy Questionnaire (PSEQ), Pain Catastrophizing Scale (PCS), International Physical Activity Questionnaire-short form (IPAQ-sf), Generalized Anxiety Disorder (GAD-7), Patient Health Questionnaire (PHQ-9), and EuroQol Five Dimensions health-related quality of life (EQ-5D-5L).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">New-onset chronic MSK pain was widespread and continuous in nature, and worse in the joints. When compared to normative values reported in the literature: a) QST revealed mechanical hyperalgesia, heightened temporal summation of pain, and hypoesthesia to vibration stimuli, which is strongly suggestive of central sensitization; b) Plasma cytokine assays indicated distinct pro-inflammatory profiles; c) TUG time indicated reduced balance and mobility; d) handgrip strength revealed general weakness; e) physical activity was lower; and f) there were moderate levels of depression and anxiety with lower self-efficacy scores and lower levels of pain catastrophizing. LC symptoms were of moderate severity (44.8/100), moderate functional disability (22.8/50) and severely compromised overall health (2.6/10) when compared to pre-COVID scores.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">New-onset chronic MSK pain in LC tends to be widespread, constant, and associated with weakness, reduced function, depression, anxiety, and reduced quality of life. There is associated central sensitization and proinflammatory state in the condition. Further research is essential to explore the longitudinal progression and natural evolution of the new-onset chronic MSK pain in LC.</AbstractText><CopyrightInformation>&#xa9; 2024 Khoja et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khoja</LastName><ForeName>Omar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-3978-6253</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva-Passadouro</LastName><ForeName>B&#xe1;rbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4668-093X</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cristescu</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McEwan</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>COVID Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doherty</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Medicine, Trinity College Dublin, Trinity Translational Medicine Institute, St. James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connell</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgery, Trinity St. James's Cancer Institute, Trinity Translational Medicine Institute, St. James's Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ponchel</LastName><ForeName>Frederique</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulvey</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6357-3848</Identifier><AffiliationInfo><Affiliation>Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astill</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9443-6934</Identifier><AffiliationInfo><Affiliation>School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ai Lyn</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-9158-7243</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivan</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0334-2968</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>J Pain Res</MedlineTA><NlmUniqueID>101540514</NlmUniqueID><ISSNLinking>1178-7090</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic widespread pain</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19</Keyword></KeywordList><CoiStatement>The authors report no conflict of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>5</Day><Hour>5</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39100135</ArticleId><ArticleId IdType="pmc">PMC11298172</ArticleId><ArticleId IdType="doi">10.2147/JPR.S466294</ArticleId><ArticleId IdType="pii">466294</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi:10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE) SIGN (SIGN) and RC of GP (RCGP). Covid 19 Rapid Guideline: Managing the Long-term Effects of Covid 19. National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP); 2022:1&#x2013;106.</Citation></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2013;461. doi:10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, et al. Post-COVID Conditions Among Adult COVID-19 Survivors Aged 18&#x2013;64 and &#x2265;65 Years. MMWR. 2022;71(21):713&#x2013;717.</Citation></Reference><Reference><Citation>Ayoubkhani D, Bosworth M, King S. Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK - Office for National Statistics. Office for National Statistics; 2023:4&#x2013;7.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C, Navarro-Santana M, Plaza-Manzano G, Palacios-Ce&#xf1;a D, Arendt-Nielsen L. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis. Pain. 2022;163(7):1220&#x2013;1231. doi:10.1097/j.pain.0000000000002496</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Halpin S, Gee J. Assessing long-term rehabilitation needs in COVID-19 survivors using a telephone screening tool (C19-YRS tool). Adv Clin Neurosci Rehabil. 2020;19(4):14&#x2013;17. doi:10.47795/nele5960</Citation><ArticleIdList><ArticleId IdType="doi">10.47795/nele5960</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoja O, Silva Passadouro B, Mulvey M, et al. Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID. J Pain Res. 2022;15:1729&#x2013;1748. doi:10.2147/JPR.S365026</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S365026</ArticleId><ArticleId IdType="pmc">PMC9212788</ArticleId><ArticleId IdType="pubmed">35747600</ArticleId></ArticleIdList></Reference><Reference><Citation>Cieza A, Causey K, Kamenov K, Hanson SW, Chatterji S, Vos T. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2021;396(10267):2006&#x2013;2017. doi:10.1016/S0140-6736(20)32340-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32340-0</ArticleId><ArticleId IdType="pmc">PMC7811204</ArticleId><ArticleId IdType="pubmed">33275908</ArticleId></ArticleIdList></Reference><Reference><Citation>Versus Arthritis. The State of Musculoskeletal Health 2021; 2021. Available from: https://www.versusarthritis.org/policy/resources-for-policy-makers/musculoskeletal-calculator/. Accessed July
25, 2024.</Citation></Reference><Reference><Citation>Perrot S, Cohen M, Barke A, Korwisi B, Rief W, Treede RD. The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain. Pain. 2019;160(1):77&#x2013;82. doi:10.1097/j.pain.0000000000001389</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001389</ArticleId><ArticleId IdType="pubmed">30586074</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntillo F, Giglio M, Paladini A, et al. Pathophysiology of musculoskeletal pain: a narrative review. Ther Adv Musculoskelet Dis. 2021:13. doi:10.1177/1759720X21995067</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759720X21995067</ArticleId><ArticleId IdType="pmc">PMC7934019</ArticleId><ArticleId IdType="pubmed">33737965</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto RBD, Reis LFF, Ferreira A de S, Alexandre DJ de A, Almeida de RS. Hospital admission is associated with disability and late musculoskeletal pain in individuals with long COVID. Front Rehabil Sci. 2023;4. doi:10.3389/fresc.2023.1186499</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fresc.2023.1186499</ArticleId><ArticleId IdType="pmc">PMC10641772</ArticleId><ArticleId IdType="pubmed">37965093</ArticleId></ArticleIdList></Reference><Reference><Citation>Erden E, Turk AC, Erden E, Dag Z. Musculoskeletal system symptoms in patients with COVID-19 and the impact of these symptoms on quality of life. J Back Musculoskelet Rehabil. 2023;36(5):1061&#x2013;1074. doi:10.3233/BMR-220297</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/BMR-220297</ArticleId><ArticleId IdType="pubmed">37458011</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvache-Mateo A, Navas-Otero A, Heredia-Ciur&#xf3; A, et al. Post-COVID patients with new-onset chronic pain 2 years after infection: cross-sectional study. Pain Manage Nurs. 2023;24(5):528&#x2013;534. doi:10.1016/j.pmn.2023.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmn.2023.04.010</ArticleId><ArticleId IdType="pmc">PMC10201348</ArticleId><ArticleId IdType="pubmed">37225540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills G, Briggs-Price S, Houchen-Wolloff L, Daynes E, Singh S. The prevalence and location of musculoskeletal pain following COVID-19. Musculoskeletal Care. 2022;20(4):972&#x2013;976. doi:10.1002/msc.1657</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/msc.1657</ArticleId><ArticleId IdType="pmc">PMC9348364</ArticleId><ArticleId IdType="pubmed">35607812</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Nijs J, Neblett R, et al. Phenotyping Post-COVID Pain as a Nociceptive, Neuropathic, or Nociplastic Pain Condition. Biomedicines. 2022;10(10):2562. doi:10.3390/biomedicines10102562</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10102562</ArticleId><ArticleId IdType="pmc">PMC9599440</ArticleId><ArticleId IdType="pubmed">36289827</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiore E, Corbellini C, Acucella L, et al. Musculoskeletal pain related to COVID-19 survivors after hospitalization: a short review. Retos. 2022;45:789&#x2013;795. doi:10.47197/retos.v44i0.90361</Citation><ArticleIdList><ArticleId IdType="doi">10.47197/retos.v44i0.90361</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033&#x2013;1034. doi:10.1016/S0140-6736(20)30628-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu QQ, Cheng A, Wang Y, et al. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study. BMJ Open. 2020;10(11):1&#x2013;10. doi:10.1136/bmjopen-2020-041471</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-041471</ArticleId><ArticleId IdType="pmc">PMC7705426</ArticleId><ArticleId IdType="pubmed">33257492</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira CMB, Sakata RK, Issy AM, Gerola LR, Salom&#xe3;o R. Cytokines and Pain. Braz J Anesthesiol. 2011;61(2):255&#x2013;265. doi:10.1016/s0034-7094(11)70029-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0034-7094(11)70029-0</ArticleId><ArticleId IdType="pubmed">21474032</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45(2):27&#x2013;37. doi:10.1097/AIA.0b013e318034194e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AIA.0b013e318034194e</ArticleId><ArticleId IdType="pmc">PMC2785020</ArticleId><ArticleId IdType="pubmed">17426506</ArticleId></ArticleIdList></Reference><Reference><Citation>Treede RD. The role of quantitative sensory testing in the prediction of chronic pain. Pain. 2019;160(1):S66&#x2013;S69. doi:10.1097/j.pain.0000000000001544</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001544</ArticleId><ArticleId IdType="pubmed">31008852</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Baron R, T&#xf6;lle TR, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain. 2010;150(3):439&#x2013;450. doi:10.1016/j.pain.2010.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2010.05.002</ArticleId><ArticleId IdType="pubmed">20627413</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. Practitioners RC of G, Scotland HI. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. NICE Guidelines; 2020:1&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23(2):129&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">8080219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholas MK. The pain self-efficacy questionnaire: taking pain into account. Eur J Pain. 2007;11(2):153&#x2013;163. doi:10.1016/j.ejpain.2005.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpain.2005.12.008</ArticleId><ArticleId IdType="pubmed">16446108</ArticleId></ArticleIdList></Reference><Reference><Citation>Vong SKS, Cheing GLY, Chan CCH, Chan F, Leung ASL. Measurement structure of the Pain Self-Efficacy Questionnaire in a sample of Chinese patients with chronic pain. Clin Rehabil. 2009;23(11):1034&#x2013;1043. doi:10.1177/0269215509337448</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0269215509337448</ArticleId><ArticleId IdType="pubmed">19656814</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: development and validation. Psychol Assess. 1995;7(4):524&#x2013;532. doi:10.1037/1040-3590.7.4.524</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/1040-3590.7.4.524</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman A, Barrios FX, Kopper BA, Hauptmann W, Jones J, O&#x2019;Neill E. Factor structure, reliability, and validity of the Pain Catastrophizing Scale. J Behav Med. 1997;20(6):589&#x2013;605. doi:10.1023/a:1025570508954</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1025570508954</ArticleId><ArticleId IdType="pubmed">9429990</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolke R, Magerl W, Campbell KA, et al. Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur. J. Pain. 2006;10(1):77. doi:10.1016/j.ejpain.2005.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpain.2005.02.003</ArticleId><ArticleId IdType="pubmed">16291301</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehm S, Sachau J, Hellriegel J, et al. Pain matters for central sensitization: sensory and psychological parameters in patients with fibromyalgia syndrome. Pain Rep. 2021;6(1):e901. doi:10.1097/pr9.0000000000000901</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/pr9.0000000000000901</ArticleId><ArticleId IdType="pmc">PMC7952123</ArticleId><ArticleId IdType="pubmed">33718743</ArticleId></ArticleIdList></Reference><Reference><Citation>Podsiadlo D, Richardson S. The timed &#x201c;Up &amp; Go&#x201d;: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142&#x2013;148. doi:10.1111/j.1532-5415.1991.tb01616.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.1991.tb01616.x</ArticleId><ArticleId IdType="pubmed">1991946</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg G. Borg &#xb4;s perceived exertion and pain scales. Human Kinetics. 1998;1998:111.</Citation></Reference><Reference><Citation>Craig CL, Marshall AL, Sj&#xf6;str&#xf6;m M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381&#x2013;1395. doi:10.1249/01.MSS.0000078924.61453.FB</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/01.MSS.0000078924.61453.FB</ArticleId><ArticleId IdType="pubmed">12900694</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the international physical activity questionnaire short form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. 2011;8(1):115. doi:10.1186/1479-5868-8-115</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5868-8-115</ArticleId><ArticleId IdType="pmc">PMC3214824</ArticleId><ArticleId IdType="pubmed">22018588</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW, L&#xf6;we B. The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32(4):345&#x2013;359. doi:10.1016/j.genhosppsych.2010.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2010.03.006</ArticleId><ArticleId IdType="pubmed">20633738</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JBW, L&#xf6;we B. A Brief Measure for Assessing Generalized Anxiety Disorder the GAD-7. American Medical Association; 2006.</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hout B, Janssen MF, Feng YS, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708&#x2013;715. doi:10.1016/j.jval.2012.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2012.02.008</ArticleId><ArticleId IdType="pubmed">22867780</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health U, Services H, for Disease Control C. Centers for Disease Control and Prevention National Center for Injury Prevention and Control; 2018.</Citation></Reference><Reference><Citation>Nicholas MK, Costa DSJ, Blanchard M, Tardif H, Asghari A, Blyth FM. Normative data for common pain measures in chronic pain clinic populations: closing a gap for clinicians and researchers. Pain. 2019;160(5):1156&#x2013;1165. doi:10.1097/j.pain.0000000000001496</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001496</ArticleId><ArticleId IdType="pubmed">30694928</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YC, Bohannon RW, Li X, Sindhu B, Kapellusch J. Hand-grip strength: normative reference values and equations for individuals 18 to 85 years of age residing in the United States. J Orthop Sports Phys Ther. 2018;48(9):685&#x2013;693. doi:10.2519/jospt.2018.7851</Citation><ArticleIdList><ArticleId IdType="doi">10.2519/jospt.2018.7851</ArticleId><ArticleId IdType="pubmed">29792107</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;we B, Decker O, M&#xfc;ller S, et al. Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population; 2008. Available from: http://journals.lww.com/lww-medicalcare. Accessed July
25, 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">18388841</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocalevent RD, Hinz A, Br&#xe4;hler E. Standardization of the depression screener Patient Health Questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry. 2013;35(5):551&#x2013;555. doi:10.1016/j.genhosppsych.2013.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2013.04.006</ArticleId><ArticleId IdType="pubmed">23664569</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen MF, Pickard AS, Shaw JW. General population normative data for the EQ-5D-3L in the five largest European economies. Eur J Health Econ. 2021;22(9):1467&#x2013;1475. doi:10.1007/s10198-021-01326-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-021-01326-9</ArticleId><ArticleId IdType="pmc">PMC8558182</ArticleId><ArticleId IdType="pubmed">34117986</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams JH, Williams AC de C. What affects return to work for graduates of a pain management program with chronic upper limb pain? J Occup Rehabil. 2003;13(2):91&#x2013;106. doi:10.1023/a:1022599731391</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1022599731391</ArticleId><ArticleId IdType="pubmed">12708103</ArticleId></ArticleIdList></Reference><Reference><Citation>Latremoliere A, Woolf CJ. Central Sensitization: a Generator of Pain Hypersensitivity by Central Neural Plasticity. J Pain. 2009;10(9):895&#x2013;926. doi:10.1016/j.jpain.2009.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2009.06.012</ArticleId><ArticleId IdType="pmc">PMC2750819</ArticleId><ArticleId IdType="pubmed">19712899</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver KR, Griffioen MA, Klinedinst NJ, et al. Quantitative Sensory Testing Across Chronic Pain Conditions and Use in Special Populations. Front Pain Res. 2021;2. doi:10.3389/fpain.2021.779068</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpain.2021.779068</ArticleId><ArticleId IdType="pmc">PMC8915716</ArticleId><ArticleId IdType="pubmed">35295425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponirakis G, Odriozola A, Ortega L, et al. Quantitative sensory testing defines the trajectory of sensory neuropathy after severe COVID-19. Diabet Res Clin Pract. 2024:207. doi:10.1016/j.diabres.2023.111029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2023.111029</ArticleId><ArticleId IdType="pubmed">38007044</ArticleId></ArticleIdList></Reference><Reference><Citation>Harte SE, Harris RE, Clauw DJ. The neurobiology of central sensitization. J Appl Biobehav Res. 2018;23(2). doi:10.1111/jabr.12137</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jabr.12137</ArticleId><ArticleId IdType="pmc">PMC6251410</ArticleId><ArticleId IdType="pubmed">30479469</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin JX, Agbana YL, Sun ZS, et al. Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis. Infect Dis Poverty. 2023;12(1):1&#x2013;14. doi:10.1186/s40249-023-01086-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-023-01086-z</ArticleId><ArticleId IdType="pmc">PMC10123579</ArticleId><ArticleId IdType="pubmed">37095536</ArticleId></ArticleIdList></Reference><Reference><Citation>Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front Med. 2023;10(March). doi:10.3389/fmed.2023.1011936</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022:434. doi:10.1016/j.jns.2022.120162</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawilska JB, Kuczy&#x144;ska K. Psychiatric and neurological complications of long COVID. J Psychiatr Res. 2022;156:349&#x2013;360. doi:10.1016/j.jpsychires.2022.10.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.10.045</ArticleId><ArticleId IdType="pmc">PMC9582925</ArticleId><ArticleId IdType="pubmed">36326545</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunney PE, Zink AN, Holm AA, Billington CJ, Kotz CM; Meints &amp; Edwards 2017. &#x4e73;&#x9f20;&#x5fc3;&#x808c;&#x63d0;&#x53d6; HHS public access. Physiol Behav. 2017;176(10):139&#x2013;148. doi:10.1016/j.pnpbp.2018.01.017.Evaluating</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2018.01.017.Evaluating</ArticleId><ArticleId IdType="pmc">PMC5510739</ArticleId><ArticleId IdType="pubmed">28363838</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills SEE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019;123(2):e273&#x2013;e283. doi:10.1016/j.bja.2019.03.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.03.023</ArticleId><ArticleId IdType="pmc">PMC6676152</ArticleId><ArticleId IdType="pubmed">31079836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou R, Chen F, Chen D, Xu CL, Xiong F. Clinical characteristics and outcome of hemodialysis patients with COVID-19: a large cohort study in a single Chinese center. Ren Fail. 2020;42(1):950&#x2013;957. doi:10.1080/0886022x.2020.1816179</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0886022x.2020.1816179</ArticleId><ArticleId IdType="pmc">PMC7534212</ArticleId><ArticleId IdType="pubmed">32924707</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanriverdi A, Savci S, Kahraman BO, Ozpelit E. Extrapulmonary features of post-COVID-19 patients: muscle function, physical activity, mood, and sleep quality. Ir J Med Sci. 2021. doi:10.1007/s11845-021-02667-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-021-02667-3</ArticleId><ArticleId IdType="pmc">PMC8172250</ArticleId><ArticleId IdType="pubmed">34080125</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers. Ann Clin Transl Neurol. 2021;8(5):1073&#x2013;1085. doi:10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, Astill SL, Sivan M. The relationship between physical activity and long COVID: a cross-sectional study. Int J Environ Res Public Health. 2022;19(9):5093. doi:10.3390/ijerph19095093</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095093</ArticleId><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb SE, J&#xf8;rstad-Stein EC, Hauer K, Becker C. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc. 2005;53(9):1618&#x2013;1622. doi:10.1111/j.1532-5415.2005.53455.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53455.x</ArticleId><ArticleId IdType="pubmed">16137297</ArticleId></ArticleIdList></Reference><Reference><Citation>Korall AMB, Steliga D, Lamb SE, Lord SR, Rabbani R, Sibley KM. Factors associated with reporting of the Prevention of Falls Network Europe (ProFaNE) core outcome set domains in randomized trials on falls in older people: a citation analysis and correlational study. Trials. 2022;23(1). doi:10.1186/s13063-022-06642-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-022-06642-w</ArticleId><ArticleId IdType="pmc">PMC9419335</ArticleId><ArticleId IdType="pubmed">36028912</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzmarzyk PT, Friedenreich C, Shiroma EJ, Lee IM. Physical inactivity and non-communicable disease burden in low-income, middle-income and high-income countries. Br J Sports Med. 2022;56(2):101&#x2013;106. doi:10.1136/bjsports-2020-103640</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2020-103640</ArticleId><ArticleId IdType="pmc">PMC8478970</ArticleId><ArticleId IdType="pubmed">33782046</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-Pe&#xf1;as C, de-La-Llave-Rinc&#xf3;n AI, Ortega-Santiago R, et al. Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: a multicenter study. Pain. 2022;163(9):E989&#x2013;E996. doi:10.1097/j.pain.0000000000002564</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002564</ArticleId><ArticleId IdType="pubmed">34913880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ora J, Calzetta L, Frugoni C, Puxeddu E, Rogliani P. Expert guidance on the management and challenges of long-COVID syndrome: a systematic review. Expert Opin Pharmacother. 2023;24(3):315&#x2013;330. doi:10.1080/14656566.2022.2161365</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2022.2161365</ArticleId><ArticleId IdType="pubmed">36542805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewthwaite H, Byrne A, Brew B, Gibson PG. Treatable traits for long COVID. Respirology. 2023;28(11):1005&#x2013;1022. doi:10.1111/resp.14596</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.14596</ArticleId><ArticleId IdType="pubmed">37715729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberman-Itskovich S, Catalogna M, Sasson E, et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep. 2022;12(1). doi:10.1038/s41598-022-15565-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15565-0</ArticleId><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee YJ, Fan BE, Young BE, Dalan R, Lye DC. Clinical trials on the pharmacological treatment of long COVID: a systematic review. J Med Virol. 2023;95(1). doi:10.1002/jmv.28289</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28289</ArticleId><ArticleId IdType="pmc">PMC9878018</ArticleId><ArticleId IdType="pubmed">36349400</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Tallawy SN, Perglozzi JV, Ahmed RS, et al. Pain Management in the Post-COVID Era&#x2014;An Update: a Narrative Review. Pain Ther. 2023;12(2):423&#x2013;448. doi:10.1007/s40122-023-00486-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40122-023-00486-1</ArticleId><ArticleId IdType="pmc">PMC9971680</ArticleId><ArticleId IdType="pubmed">36853484</ArticleId></ArticleIdList></Reference><Reference><Citation>Navani A. Literature review a multidisciplinary rehabilitation approach to chronic pain patients in the post-COVID-19 era. Pain Physician. 2023;26(5):457&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">37774184</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandan JS, Brown KR, Simms-Williams N, et al. Non-pharmacological therapies for post-viral syndromes, including long COVID: a systematic review. Int J Environ Res Public Health. 2023;20(4):3477. doi:10.3390/ijerph20043477</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20043477</ArticleId><ArticleId IdType="pmc">PMC9967466</ArticleId><ArticleId IdType="pubmed">36834176</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinert G, M&#xfc;ller D, Wagner P, et al. Pulmonary rehabilitation in SARS-CoV-2: a systematic review and meta-analysis of post-acute patients. Diagnostics. 2022;12(12):3032. doi:10.3390/diagnostics12123032</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12123032</ArticleId><ArticleId IdType="pmc">PMC9776761</ArticleId><ArticleId IdType="pubmed">36553039</ArticleId></ArticleIdList></Reference><Reference><Citation>Mel&#xe9;ndez-Oliva E, Mart&#xed;nez-Pozas O, Cuenca-Zald&#xed;var JN, Villafa&#xf1;e JH, Jim&#xe9;nez-Ortega L, S&#xe1;nchez-Romero EA. Efficacy of pulmonary rehabilitation in post-covid-19: a systematic review and meta-analysis. Biomedicines. 2023;11(8):2213. doi:10.3390/biomedicines11082213</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11082213</ArticleId><ArticleId IdType="pmc">PMC10452542</ArticleId><ArticleId IdType="pubmed">37626710</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Pozas O, Mel&#xe9;ndez-Oliva E, Rolando LM, Rico JAQ, Corbellini C, S&#xe1;nchez Romero EA. The pulmonary rehabilitation effect on long covid-19 syndrome: a systematic review and meta-analysis. Physiother Res Int. 2024;29(2). doi:10.1002/pri.2077</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pri.2077</ArticleId><ArticleId IdType="pubmed">38389299</ArticleId></ArticleIdList></Reference><Reference><Citation>Artiles-S&#xe1;nchez J, Fern&#xe1;ndez-Carnero J, S&#xe1;nchez-Romero EA, et al. Multicomponent exercise program to avoid productivity loss due to COVID-19 A prospective study with a brief report of 2-year follow-up. Top Geriatr Rehabil. 2024;40(2):175&#x2013;183. doi:10.1097/TGR.0000000000000439</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TGR.0000000000000439</ArticleId></ArticleIdList></Reference><Reference><Citation>Valverde-Mart&#xed;nez M&#xc1;, L&#xf3;pez-Liria R, Mart&#xed;nez-Cal J, Benzo-Iglesias MJ, Torres-&#xe1;lamo L, Rocamora-P&#xe9;rez P. Telerehabilitation, A viable option in patients with persistent post-COVID syndrome: a systematic review. Healthcare. 2023;11(2):187. doi:10.3390/healthcare11020187</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11020187</ArticleId><ArticleId IdType="pmc">PMC9859291</ArticleId><ArticleId IdType="pubmed">36673555</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansoubi M, Dawes J, Bhatia A, et al. Digital home monitoring for capturing daily fluctuation of symptoms; A longitudinal repeated measures study: long Covid Multi-disciplinary Consortium to Optimise Treatments and Services across the NHS (a LOCOMOTION study). BMJ Open. 2023;13(8):e071428. doi:10.1136/bmjopen-2022-071428</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-071428</ArticleId><ArticleId IdType="pmc">PMC10414119</ArticleId><ArticleId IdType="pubmed">37553189</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol. 2020;16(11):645&#x2013;660. doi:10.1038/s41584-020-00506-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-00506-w</ArticleId><ArticleId IdType="pubmed">33024295</ArticleId></ArticleIdList></Reference><Reference><Citation>Buskila D, Atzeni F, Sarzi-Puttini P. Etiology of fibromyalgia: the possible role of infection and vaccination. Autoimmun Rev. 2008;8(1):41&#x2013;43. doi:10.1016/j.autrev.2008.07.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2008.07.023</ArticleId><ArticleId IdType="pubmed">18706528</ArticleId></ArticleIdList></Reference><Reference><Citation>Fialho MFP, Brum ES, Oliveira SM. Could the fibromyalgia syndrome be triggered or enhanced by COVID-19? Inflammopharmacology. 2023;31(2):633&#x2013;651. doi:10.1007/s10787-023-01160-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01160-w</ArticleId><ArticleId IdType="pmc">PMC9970139</ArticleId><ArticleId IdType="pubmed">36849853</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Passadouro B, Tamasauskas A, Khoja O, et al. A systematic review of quantitative EEG findings in Fibromyalgia, Chronic Fatigue Syndrome and Long COVID. Clin Neurophysiol. 2024;163:209&#x2013;222. doi:10.1016/j.clinph.2024.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2024.04.019</ArticleId><ArticleId IdType="pubmed">38772083</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams ACDC. Defeating the stigma of chronic pain. Pain. 2016;157(8):1581&#x2013;1582. doi:10.1097/j.pain.0000000000000530</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000000530</ArticleId><ArticleId IdType="pubmed">26934511</ArticleId></ArticleIdList></Reference><Reference><Citation>Bean DJ, Dryland A, Rashid U, Tuck NL. The determinants and effects of chronic pain stigma: a mixed methods study and the development of a model. J Pain. 2022;23(10):1749&#x2013;1764. doi:10.1016/j.jpain.2022.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2022.05.006</ArticleId><ArticleId IdType="pubmed">35700874</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner JA. Pain and Disability. Vol. 32. Clinical, Behavioral, and Public Policy Perspectives (Institute of Medicine Committee on Pain, Disability, and Chronic Illness Behavior).;1988. doi:10.1016/0304-3959(88)90054-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3959(88)90054-1</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>